|
Sep 3
|
Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio
|
|
Aug 29
|
Annexon Biosciences to Participate in Upcoming September Investor Conferences
|
|
Aug 3
|
Annexon Insider Ups Holding During Year
|
|
Jun 25
|
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting
|
|
May 14
|
We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth
|
|
May 13
|
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
|
|
May 9
|
Annexon Biosciences to Present at the Bank of America Health Care Conference
|
|
May 7
|
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
|
|
May 1
|
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
|
|
May 1
|
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
|
|
Apr 25
|
Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)
|
|
Apr 17
|
Are Medical Stocks Lagging Annexon (ANNX) This Year?
|
|
Apr 16
|
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 16
|
Turnstone Biologics Appoints William Waddill to its Board of Directors
|
|
Apr 14
|
10 Buy-Rated Stocks with Latest Insider Purchases
|
|
Apr 10
|
Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Apr 3
|
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Apr 1
|
What Makes Annexon (ANNX) a New Buy Stock
|
|
Apr 1
|
Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade
|
|
Mar 28
|
Annexon Inc (ANNX) Reports Year-End Financials, Aligns with Analyst Projections
|